Prognostic and predictive clinical, pathological, and molecular biomarkers in metastatic colorectal carcinoma – a review
Ongoing research increasingly reveals that metastatic colorectal carcinoma (mCRC) is a highly heterogeneous entity. Despite extension of the median survival of mCRC patients due to advances in therapeutic options available, further improvement …